Health problems rarely get solved without local ownership and involvement. Poor countries need not only their own doctors and nurses, but their own researchers and research infrastructure. This session will provide 3 examples from innovative partnerships of international organizations and pharmaceutical companies showing how several countries in Africa are building research capacity, and out of that, extended community-based healthcare systems and economic development. Field researchers will explain the development of a new drug and new research facilities to combat river blindness (onchocerciasis) in war-torn Africa; a research study that documents for the first time how remote, rural communities can provide a variety of health services and double access to malaria treatments; and a collaborative north-south research effort to implement a massive Phase III trial - 40,000 participants over four years - to license a new tuberculosis (TB) vaccine that could help end this epidemic that kills nearly two million people each year.

Multimedia files

Audio clip: 

You are missing some Flash content that should appear here! Perhaps your browser cannot display it, or maybe it did not initialize correctly.

Lunch Session 01.mp3